Monoclonal antibody specific for human colon fibroblast-derived T-PA

Patent · Tue May 23 00:00:00 EDT 1989

OSTI ID:5821869

Schaumann, J P; Olander, J V; Harakas, N K; Feder, J

This patent describes a murine-derived hybridoma cell line capable of producing monoclonal antibody against human colon fibroblast-derived tissue plasminogen activator and the cell line selected from the group consisting of cell lines 63-4 (ATCC HB 9155), 54-2 (ATCC HB 9157) or 79-7 (ATCC HB 9156).

• Assignee: Monsanto Co., St. Louis, MO
• Patent Number(s): US 4833085
• OSTI ID: 5821869
• Resource Relation: Patent File Date: Filed date 13 Aug 1986
• Country of Publication: United States
• Language: English

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
HYBRIDOMAS
LARGE INTESTINE
FIBROBLASTS
MONOCLONAL ANTIBODIES
PRODUCTION
MAN
PLASMINOGEN
THERAPY
ANIMAL CELLS
ANIMALS
ANTIBODIES
BODY
CONNECTIVE TISSUE CELLS
DIGESTIVE SYSTEM
DRUGS
FIBRINOLYTIC AGENTS
GASTROINTESTINAL TRACT
HEMATOLOGIC AGENTS
INTESTINES
MAMMALS
ORGANS
PRIMATES
SOMATIC CELLS
VERTEBRATES
550300* - Cytology
550600 - Medicine